Description:
E3F05 Second Primary Form Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDAKeywords:
Versions (3)
- 8/26/12 8/26/12 -
- 1/9/15 1/9/15 - Martin Dugas
- 6/16/15 6/16/15 -
Uploaded on:
August 26, 2012
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Brain and Central Nervous System Tumors NCT00978458 Registration - E3F05 Second Primary Form - 2926619v1.0
INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead
- StudyEvent: E3F05 Second Primary Form